Keywords: boehringer, ingelheim, spiriva, reduces, attacks, hospitalizations, copd

Boehringer Ingelheim's Spiriva reduces attacks and hospitalizations in COPD patients

Article | 31 May 2004

Print This

New data presented at the 100th international conference of the American Thoracic Society, held in Orlando, Florida, show that Germany-based ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in